We report a 13 year old boy with fragile X syndrome resulting from a de nov
o deletion of the FMR1 and FMR2 genes extending from (and including) DXS753
6 proximally to FMR2 distally. The patient has severe developmental delay,
epilepsy, and behavioural difficulties, including autistic features. He has
epicanthic folds, in addition to facial features typical of fragile X synd
rome, and marked joint hypermobility. We compare our patient to the three o
ther cases reported in which both FMR1 and FMR2 are deleted. This case has
the smallest deletion reported to date. All four patients have epilepsy and
a more severe degree of mental retardation than is usual in fragile X synd
rome resulting from FMR1 triplet repeat expansion. Three of the patients ha
ve joint laxity and two have epicanthic folds. We suggest that these featur
es, in particular severe developmental delay and epilepsy, may form part of
the characteristic phenotype resulting from deletion of both FMR1 and FMR2
genes. The diagnosis in this case was delayed because routine cytogenetics
showed no abnormality and standard molecular tests for FMR1 triplet repeat
expansion (PCR and Southern blotting) failed. Further DNA studies should b
e undertaken to investigate for a deletion where clinical suspicion of frag
ile X syndrome is strong and routine laboratory tests fail.